Shaw Christi

Shaw Christi is listed in filings as Executive Chairperson at Kyverna Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jun 5, 2026, including 4 public disclosures. Recent filings connect the profile to Kyverna Therapeutics, Inc. (KYTX) and Beam Therapeutics Inc. (BEAM). The current snapshot covers public activity from Jan 14, 2026 to Jun 5, 2026. Reported amounts are shown as $1.5M to $581.4K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.